Synthetic Biologics (SYN) Tops Q1 EPS by 5c

Synthetic Biologics (NYSE: SYN) reported Q1 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• Pony AI (PONY) Reports Revenue Above Estimates
• Compass Point Starts Gorilla Tech Group/ (GRRR) at Buy